:cries: Introducing a new antigen-antibody reaction enhancer : SAN enhancer (SANE) After 20 years of hard work, I have invented a new kind of antigen-antibody reaction enhancer - SAN enhancer (SANE), it can be in the gel cards and the application of test tube method. SANE in the gel card, also known as "micro-gel enhancer" (Micro-column gel enhancer, MGE); SANE law in a test tube, also known as "test-tube method enhancer" (Test-tube method enhancer, TME ). SANE in the test tube method in blood group serology testing, instead of an indirect anti-human globulin test(IAT). After incubated in one minute can detect of red cell blood group IgG antibodies. The following are the specific steps 一、[MGE method steps] - gel card applications 50ul 1% of the red blood cell saline solution + 50ul serum / plasma + 50ul MGE, 37 ℃ incubated for 1 minute, centrifuged (900rpm, 2min, and then 2300rpm ,3-4min. Or 2000rpm, 5min.), The naked eye or equipment to read the results. Red blood cells sink to the bottom of the micro-column gel card negative reaction, if the red blood cells in the micro-column gel card or the top of the upper part of the positive reaction. Disadvantages: At present, MGE method can not detect a large number of 0.9% NaCl containing serum samples, as a pure saline can lead to false-positive reaction, so MGE method can not be used 0.9% NaCl as diluent for antibody titer test. 二、[TME method steps] - Application of test-tube method 50ul of 3% of the red blood cell saline solution +100 ul of serum / plasma + 100ul TME, 37 ℃ incubated for 1 minute, centrifuged (3100rpm, 15s; or 1000rpm, 1min.), The naked eye to read the results. Erythrocyte agglutination there is a positive reaction, whereas no agglutination for the negative. Benefits: TME can be used for serum, plasma, saline test, 0.9% NaCl will not lead to false-positive reaction, it can be used for detection of antibody titer, For example, determination of pregnant woman blood serum IgG anti-A ( titre . TME has been completed Drug Registrationin a country FDA ( TME has obtained a national FDA the drugs registration form). TME-related cross-matching (compatibility test) kit will be supplied in a country of the Asian marketin November 2009. Would welcome further research cooperation. SUN Ai-nong (Director, Professor) E-mail: sunainong@21cn.com